The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions

NCT06244407 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

NETWORK

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Vildagliptin and Metformin Hydrochloride 50mg 1000 mg Film-coated Tablets

Sponsor

International Bio service